LinkedIn automations are now retired. TexAu V3 is on the way, be the first to know when it launches.

Get updates

How Much Did Solugen Raise? Headquarters, Funding & Key Investors

Solugen, a Houston-based sustainable chemical manufacturer, has raised $855.8 million across multiple funding rounds, including a $200 million Series D led by Kinnevik, Lowercarbon Capital, and Refactor. The company reached a $2 billion valuation in 2022 and later secured a $213.6 million U.S. Department of Energy loan to scale operations. With top investors such as Baillie Gifford, GIC, and Founders Fund, Solugen continues to innovate in biotechnology and clean manufacturing—creating carbon-negative molecular platforms that replace petroleum-based chemicals with sustainable, plant-derived alternatives.

    Solugen develops sustainable, bio-based chemicals through its proprietary biotechnology platform, which combines synthetic biology, enzyme engineering, and modular plant design. Its products serve multiple industries from agriculture and water treatment to oil & gas, concrete admixtures, and cleaning reducing environmental impact while maintaining industrial efficiency.

    What Is Solugen and What Does It Do?

    Solugen, founded in 2016 by Gaurab Chakrabarti and Sean Hunt, is based in Houston, Texas. The company manufactures carbon-negative, bio-based chemicals by combining synthetic biology, metal catalyst engineering, and AI-powered modular design.

    Solugen employs between 101 and 250 people. Its technology replaces petroleum-derived products with sustainable plant-based substitutes, driving innovation in sectors like renewable fuels, water treatment, and industrial materials. The firm’s mission is to make the world’s chemical infrastructure cleaner, safer, and more efficient through the application of advanced biotechnology.

    How Much Funding Has Solugen Raised?

    1. Seed Round

    • Amount Raised: $4.4 million
    • Date: October 2017
    • Lead Investors: Refactor
    • Motivation: To expand the founding team and develop early-stage bio-manufacturing technology.

    2. Series A 

    • Amount Raised: $18.8 million
    • Date: October 2018
    • Lead Investors: Founders Fund
    • Motivation: To scale production capabilities and refine core technology.

    3. Series B 

    • Amount Raised: $32 million
    • Date: May 2019
    • Lead Investors: Founders Fund
    • Motivation: To increase production capacity and market reach.

    4. Series B (Extension)

    • Amount Raised: $30 million
    • Date: April 2020
    • Lead Investors: Refactor
    • Motivation: To commercialize and accelerate technology adoption.

    5. Series C

    • Amount Raised: $357 million
    • Date: September 2021
    • Lead Investors: Baillie Gifford, GIC
    • Motivation: To reach unicorn status and expand global presence.

    6. Series D 

    • Amount Raised: $200 million
    • Date: October 2022
    • Lead Investors: Kinnevik, Lowercarbon Capital, Refactor
    • Motivation: To strengthen market position and accelerate scale-up.

    7. Debt Financing

    • Amount Raised: $213.6 million
    • Date: June 2024
    • Lead Investors: U.S. Department of Energy
    • Motivation: To fund the Bioforge Marshall facility and expand production without equity dilution.

    Total Funding Raised: $855.8 Million

    Current Valuation: $2 Billion (as of Nov 2022)

    Latest Funding Date: June 2024

    Key Investors

    1. Fifty Years

    • Details: A venture fund backing early-stage companies solving global sustainability and health challenges.
    • Investment Focus Areas: Biotechnology, Food Tech, and Clean Manufacturing.
    • Notable Investments: Upside Foods, Solugen, New Culture.

    2. Refactor Capital

    • Details: An early-stage venture capital firm supporting breakthrough technology ventures.
    • Investment Focus Areas: Technology, biotech, sustainability.
    • Notable Investments: Solugen, Future Family.

    3. Founders Fund

    • Details: A San Francisco-based venture capital firm investing across technology and science sectors.
    • Investment Focus Areas: Technology, biotech, space exploration.
    • Notable Investments: SpaceX, Palantir, Airbnb.

    4. Baillie Gifford

    • Details: An Edinburgh-based investment management firm emphasizing long-term growth strategies.
    • Investment Focus Areas: Technology, healthcare, renewable energy.
    • Notable Investments: Tesla, Amazon, Alibaba.

    Where Is Solugen’s Headquarters?

    Solugen is headquartered in Houston, Texas, a city renowned for its robust industrial base and proximity to significant energy and chemical markets. Houston’s infrastructure, access to feedstock suppliers, and strong talent pool enable Solugen to manufacture and distribute sustainable bio-based chemicals across North America efficiently.

    What’s Next for Solugen?

    Solugen is expanding through the Bioforge Marshall facility, a 500,000-sq-ft biomanufacturing plant in Southwest Minnesota. Backed by a $213.6 million U.S. DOE loan, the facility will produce bio-based chemical products for wastewater treatment, agriculture, and construction. Expected to reduce carbon emissions by 18 million kilograms annually, the project underscores Solugen’s mission to revolutionize industrial chemistry, aligning with the White House’s Justice 40 Initiative and global sustainability goals.

    Get Investor & Funding Insights with TexAu

    TexAu helps sales and business teams uncover detailed fundraising information on companies like Solugen. Use the platform to research investors, track funding rounds, and gather actionable insights to strengthen prospecting and business strategy.


    Sign Up for Freeon TexAu and start uncovering detailed funding insights that give your business a competitive edge.

    Start your 14-day free trial today, no card needed

    TexAu updates, tips and blogs delivered straight to your inbox.